Charles Schwab
FURX

Charles Schwab’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Charles Schwab’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,978
Closed -$2.33M – 3115
2014
Q2 		$2.33M Buy
21,978
+872
+4% +$85.5K ﹤0.01% 1901
2014
Q1 		$1.84M Buy
21,106
+1,680
+9% +$130K ﹤0.01% 2003
2013
Q4 		$817K Buy
19,426
+576
+3% +$23.7K ﹤0.01% 2365
2013
Q3 		$841K Buy
18,850
+1,832
+11% +$75.8K ﹤0.01% 2298
2013
Q2 		$612K Buy
+17,018
New +$597K ﹤0.01% 2425

Charles Schwab's FURX Position: Q3 2014 in Review

Charles Schwab sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 21,978 shares — an estimated $2.33M sold.

Charles Schwab first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.33M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Charles Schwab reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Charles Schwab sold 21,978 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $2.33M.
  • Charles Schwab first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Charles Schwab's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.33M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Charles Schwab's 13F filing for Q3 2014, filed 10 Nov 2014.